Table 3.
Summary of adverse events
DETP (n = 68) | Placebo (n = 66) | |
---|---|---|
Adverse events, n (%) | 2 (3.0%) | 3 (4.5%) |
Skin | ||
Pruritus | 1 (1.5%) | 2a (3.0%) |
Other (application site burning) | 0 (0.0%) | 1 (1.5%) |
Body as a whole | ||
Allergic reaction | 1 (1.5%) | 0 (0.0%) |
Note:
One event led to discontinuation of the study treatment.
Abbreviations: DETP, diclofenac epolamine topical patch; n, number of patients.